glp-1 dementia study and Alzheimer's Disease: Research on Neuroprotective Potential Studies comparing effects of GLP1-receptor
Description
Conclusion Longterm GLP1 obesity treatment represents an important evolution in diabetes care
Retatrutide's pending approval might change the landscape, but patients should remain in communication with their healthcare providers about cost expectations and insurance coverage
The analogue has the same action as GLP-1
Both can be minimized with adequate protein intake
Most are given by injection, but there is one pill option (Rybelsus)
